Table 4 Retention times and mass spectral patterns (mass-to-charge ratio, m/z) of the compound GLB and its metabolites (M1 and M2) identified by UPLC-QTOF-MS/MS method in rat plasma after oral administration (100 mg/kg).

From: Quantitative and qualitative analysis of the novel antitumor 1,3,4-oxadiazole derivative (GLB) and its metabolites using HPLC-UV and UPLC-QTOF-MS

Peak

Mass Error (ppm)

Retention Time (min)

Calculated Mass

Identification

Formula

Molecular Ion (m/z)

Fragment Ions (m/z)

GLB

1.0

3.50

496.08

Parent compound

C21H25N2O7Br

497 [M+H]+

     

520 [M+Na]+

     

C18H10N2 O6Br

441

M1

−0.8

2.56

528.07

Di-hydroxylation

C21H25N2O9Br

529 [M+H]+

     

553 [M+Na]+

     

C18H20N2O7Br

457

     

C21H25N2O9

449

     

C18H18N2O6Br

435

     

C16H18N2O6Br

401

M2

−0.1

2.86

512.08

Hydroxylation

C21H25N2O8Br

513 [M+H]+

     

537 [M+Na]+

     

C18H20N2O7Br

457

     

C19H20N2O5Br

437

     

C17H20NO6Br

413